INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE (Q2069417)

From EU Knowledge Graph
Revision as of 13:46, 16 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2069417 in Italy
Language Label Description Also known as
English
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE
Project Q2069417 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    581,273.55 Euro
    0 references
    budget
    1,162,547.1 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    7 November 2016
    0 references
    expected end time
    31 December 2019
    0 references
    beneficiary name (string)
    STERLING S.P.A.
    0 references
    beneficiary
    Q293620
    0 references
    programme
    Umbria - ERDF
    0 references
    coordinate location

    43°7'44.51"N, 12°17'15.79"E
    0 references
    summary
    PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE - SINTESI DI SMALL MOLECULE (Italian)
    0 references
    INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE DRUGS FOR CANCER AND METABOLISM (English)
    0 references
    PLATEFORME INTÉGRÉE POUR LA RECHERCHE ET LE DÉVELOPPEMENT DE MÉDICAMENTS INNOVANTS POUR LE CANCER ET LES MALADIES MÉTABOLIQUES — RÉSUMÉ DES PETITES MOLÉCULES (French)
    point in time
    16 December 2021
    0 references

    Identifiers

    Italian Unique Project Code
    I38I16000150007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2069417&oldid=19884982"